Pfizer Inc. said Wednesday it will ask health regulators to authorize its experimental Covid-19 vaccine within days, after reporting the shot was 95% effective in its pivotal study and showing signs of being safe.
The company’s plans mean the shot is on track to go into distribution by the end of the year, if the regulators permit.
Out of…
This post first appeared on wsj.com
